Carson Wealth (CWM LLC)
BIVV

Carson Wealth (CWM LLC)’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-26
Closed -$1K – 1626
2017
Q4 		$1K Hold
26
– – ﹤0.01% 1437
2017
Q3 		$1K Hold
26
– – ﹤0.01% 1452
2017
Q2 		$2K Buy
26
+4
+18% +$228 ﹤0.01% 1055
2017
Q1 		$1K Buy
+22
New +$1.08K ﹤0.01% 1145

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Carson Wealth (CWM LLC)'s BIVV Position: Q1 2018 in Review

Carson Wealth (CWM LLC) sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 26 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Carson Wealth (CWM LLC) reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 26 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1K.
  • Carson Wealth (CWM LLC) first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Carson Wealth (CWM LLC)'s Bioverativ Inc. Common Stock position peaked at $2K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2018, filed 26 Apr 2018.